The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases C Bruni, S Gentileschi, G Pacini, C Baldi, M Capassoni, L Tofani, ... Therapeutic Advances in Musculoskeletal Disease 12, 1759720X20964031, 2020 | 24 | 2020 |
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from systematic literature review and from real life experience E Agostini, G De Luca, C Bruni, F Bartoli, L Tofani, C Campochiaro, ... Autoimmunity Reviews 20 (12), 102981, 2021 | 13 | 2021 |
Comparison of ultrasound attenuation by calcium pyrophosphate, hydroxyapatite and monosodium urate crystals: a proof-of-concept study G Filippou, G Pacini, S Sirotti, M Zadory, D Carboni, A Damiani, ... Annals of the Rheumatic Diseases 81 (8), 1199-1201, 2022 | 11 | 2022 |
The ultrasonographic pseudo-double contour sign in calcium pyrophosphate deposition disease: an anatomic explanation and how to distinguish it from gout G Filippou, M Miguel-Pérez, L Coronel, S Sirotti, G Pacini, A Scanu, ... Arthritis & rheumatology (Hoboken, NJ) 75 (4), 639-640, 2023 | 8 | 2023 |
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis C Bruni, S Gentileschi, G Pacini, M Bardelli, L Tofani, F Bartoli, C Baldi, ... Therapeutic Advances in Musculoskeletal Disease 13, 1759720X211033679, 2021 | 7 | 2021 |
THU0394 Enthesitis in systemic sclerosis (SSC): an ultrasound (US) pilot study R Terenzi, R Karalilova, S Bellando-Randone, S Guiducci, M Manetti, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 412-412, 2018 | 2 | 2018 |
Persistence of remission after lengthening of golimumab in inflammatory joint diseases A Damiani, F Bartoli, G Pacini, D Carboni, SB Randone, G Fiori, ... Clinical and Experimental Rheumatology, 0-0, 2023 | 1 | 2023 |
Corrigendum to" Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience"[Autoimmunity … E Agostini, G De Luca, C Bruni, F Bartoli, L Tofani, C Campochiaro, ... Autoimmunity reviews 22 (1), 103198, 2023 | | 2023 |
POS0132 THE FIRST ALGORITHM TO INTEGRATE ULTRASONOGRAPHY IN THE DIAGNOSTIC PROCESS OF DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY ARTHROPATHY IN CLINICAL PRACTICE: A STUDY FROM THE … A Damiani, G Sakellariou, A Adinolfi, CA Scirè, G Pacini, E Fiorentini, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 292-293, 2022 | | 2022 |
POS0278 COMPARISON OF ULTRASOUND BEAM ATTENUATION BY CALCIUM PYROPHOSPHATE, HYDROXYAPATITE AND MONOSODIUM URATE CRYSTALS: A PROOF-OF-CONCEPT STUDY G Pacini, G Filippou, S Sirotti, M Zadory, D Carboni, A Damiani, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 382-383, 2022 | | 2022 |
STRATEGIE PER IMPLEMENTARE NEL CONTESTO ITALIANO LE “RECOMMENDATIONS FOR THE IMPLEMENTATION OF SELF-MANAGEMENT STRATEGIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS” DI EULAR (2021) MR Melis, K El Aoufy, S Battista, EM Camerone, S Bellando Randone, ... REUMATISMO, 468-468, 2022 | | 2022 |
Brief paper Rheumatology residency in a European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases centre: opportunities and challenges E Dourado, AT Melo, G Pacini, A Pankow, P Klemm, AR Cruz-Machado Clin Exp Rheumatol 40 (134), S63-S65, 2022 | | 2022 |
AB0281 SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE. C Bruni, S Gentileschi, M Capassoni, G Pacini, M Bardelli, C Baldi, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 1439-1440, 2020 | | 2020 |